Speaker Articles

Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate Biopharma's Approach, Part I.
Co-Authors:
David Knepper, Head, Continuous Improvement, Forest Laboratories
Andy Lawton, Global Head, Data Management, Biometrics & Data Management, Boehringer Ingelheim Ltd.

Read Article

Technology Considerations to Enable the Risk-Based Monitoring Methodology
Contributing Author: Shelly Barnes, Senior Project Manager, Global Clinical Solution Center – Strategy and Innovation, Sanofi
Read Article


Interviews

February 13, 2019 Clinical Research News
Clinical Trials In The Age Of Data Marina Filshtinsky, Executive Director of Conferences at Cambridge Healthtech Institute

February 2019 Yprime Blog Post
SCOPE 2019 Summary – Beyond the Pilot, Moving Towards Implementation Donna Mongiello, RN, BSN, Vice President Strategic Solutions, YPrime

February 12, 2019 Clinical Research News
IRT Developers, Engineers See The Patient Beneath The Data an interview with Andrew Rohrbaugh, Director of Client Delivery at Cenduit

February 7, 2019 Clinical Research News
Doing More With Less: The Road To Success For Clinical Trials an interview with Rosie Filling, Vice President of Clinical Development Operations at Endo

February 5, 2019 Clinical Research News
The Informed Patient: How Biosample Management Is Evolving For Consent an interview with Caoimhe Vallely-Gilroy, head, Clinical trial biosample management and informed consent at Merck KGaA

February 1, 2019 Clinical Research News
How Real World Data Changes Clinical Trials, And What That Means For Patients an interview with Martin Marciniak, US Medical Affairs Vice President, leading the Customer Engagement Value Evidence and Outcomes Team at GlaxoSmithKline

January 31, 2019 Clinical Research News
Real Risk, Real Quality: Risk-Based Monitoring In Clinical Trials Today

January 28, 2019 Clinical Research News
A Realist Looks At AI In Clinical Trials an interview with Ronald Dorenbos, Associate Director Materials & Innovation, digital strategies group for neuroscience at Takeda

January 11, 2019 Clinical Informatics News
The Future Of Real World Data In Clinical Trials an interview with Cathy Critchlow, Vice president and head of the Center for Observational Research, Amgen

January 9, 2019 Clinical Informatics News
Starting Line: How To Begin Getting Patient Input Into Clinical Trial Design an interview with Beth Zaharoff, Director of patient-focused clinical trial engagement at TESARO

How Real World Data Changes Clinical Trials, And What That Means For Patients
With: Martin Marciniak, PhD, Vice President, US Medical Affairs, Customer Engagement, Value, Evidence & Outcomes, GSK
Read Interview

Real Risk, Real Quality: Risk-Based Monitoring In Clinical Trials Today

With: Andy Lawton, Director & Consultant, Risk Based Approach Ltd.
Read Interview

A Realist Looks at AI In Clinical Trials
With: Ronald Dorenbos, PhD, Associate Director, Materials and Innovation, Takeda Pharmaceuticals
Read Interview

Are We Ready for AI In Clinical Trials?

With: Francis Kendall, Director, Biostatistics & Programming, Cytel, Inc.
Read Interview

Preparing CRAs to be Site Recruitment Managers: The Pros, the Cons and The Process
With: Beth Harper, President, Consultant, CPP, Inc.
Nikki Christison, President, Consultant, Clinical Resolutions, Inc.
Gretchen Goller, Senior Director, Patient Access and Retention Services, PRA International

Read Interview

Kelly Zou: Mathematics, Statistics, Data Science, and Dreams
Kelly Zou, Ph.D., PStat®, Senior Director and Analytic Science Lead, Real World Data & Analytics (RWDnA), Global Health & Value (GH&V), Pfizer, Inc.
Read Interview

Kelly Zou: Meet Inspirational Women in Statistics & Data Science
Kelly Zou, Ph.D., PStat®, Senior Director and Analytic Science Lead, Real World Data & Analytics (RWDnA), Global Health & Value (GH&V), Pfizer, Inc.
Read Interview


Podcasts

Clinical Trial Contracting Challenges: Streamlining CTA Negotiations Beyond Legal Language

Débora Araujo, Associate Director, Site Budgets and Payments (US Group Head), Boehringer Ingelheim Pharmaceuticals, Inc.

Débora Araujo of Boehringer Ingelheim spoke to CHI to discuss her expertise in clinical trial agreements and some of the daily challenges she faces in negotiations and contracts. She specifically discusses some of the key barriers within and beyond the legal language of CTAs and also shares highlights from her forthcoming book, The Four Villains of Clinical Trial Agreement Delays and How to Defeat Them.


Clinical Trials: Patient Centricity and Wearables

Jaydev Thakkar, Clinical Trial Design and Management, Global IS Service Owner, Director Information Systems, Amgen
Jaydev Thakkar of Amgen speaks to CHI on November 1st, 2016. Dr. Thakkar will be speaking during the Clinical Technology and Innovation conference at the SCOPE Summit, January 24-26, 2017 in Miami, FL.

Topics include patient engagement from a data management perspective, using wearables to lower patient burden and tapping into novel endpoints.


Managing Precision Medicine Clinical Trials

Brenda Yanak, Ph.D., Director, Precision Medicine Leader, Clinical Innovation, Pfizer
Brenda Yanak of Pfizer speaks to CHI on Oct 31, 2016. Dr. Yanak will be speaking during the Managing Precision Medicine Trials symposium at the SCOPE Summit, January 24-26, 2017 in Miami, FL.

Topics include the Transcelerate consortium, consent management and the importance of bio-banking in precision medicine.